Small Cell Lung Cancer Patients Can Benefit from Immunotherapy

Small Cell Lung Cancer Patients Can Benefit from Immunotherapy

Da: GRACEcast
0 0 5 anni fa
The current standard of care for SCLC shows limited results with high toxicities. Drs. Soria, Gandhi, and West discuss new ASCO 2015 data that show promise for a subset of patients with PD-L1 expression on Keytruda (pembrolizumab) or Opdivo (nivolumab).

Seguici su Facebook